Provexis (LSE:PXS) Days Sales Outstanding : 19.06 (As of Sep. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Provexis Days Sales Outstanding?

Provexis's average Accounts Receivable for the six months ended in Sep. 2024 was £0.08 Mil. Provexis's Revenue for the six months ended in Sep. 2024 was £0.79 Mil. Hence, Provexis's Days Sales Outstanding for the six months ended in Sep. 2024 was 19.06.

The historical rank and industry rank for Provexis's Days Sales Outstanding or its related term are showing as below:

LSE:PXS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 1.55 Med: 3.86 Max: 43.43
Current: 43.43

During the past 13 years, Provexis's highest Days Sales Outstanding was 43.43. The lowest was 1.55. And the median was 3.86.

LSE:PXS's Days Sales Outstanding is ranked better than
78.61% of 963 companies
in the Drug Manufacturers industry
Industry Median: 72.11 vs LSE:PXS: 43.43

Provexis's Days Sales Outstanding declined from Sep. 2023 (63.03) to Sep. 2024 (19.06).

Provexis Days Sales Outstanding Historical Data

The historical data trend for Provexis's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Provexis Days Sales Outstanding Chart

Provexis Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Days Sales Outstanding

Get a 7-Day Free Trial

4.20

3.98

4.28

3.74

5.23

Provexis Semi-Annual Data
	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Days Sales Outstanding	Get a 7-Day Free Trial															73.92	62.71	63.03	62.38	19.06

Competitive Comparison of Provexis's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Provexis's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Provexis's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Provexis's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Provexis's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

Provexis Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Provexis's Days Sales Outstanding for the fiscal year that ended in Mar. 2024 is calculated as

	Days Sales Outstanding (A: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0.004	+	0.019)	/	2 )	/	0.802	*	365
=	0.0115					/	0.802	*	365
=	5.23

Provexis's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding (Q: Sep. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2024 )	+	Accounts Receivable (A: Sep. 2024 ))	/	count )	/	Revenue (A: Sep. 2024 )	*	Days in Period
=	( (0.019	+	0.145)	/	2 )	/	0.785	*	365 / 2
=	0.082					/	0.785	*	365 / 2
=	19.06

Provexis (LSE:PXS) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Provexis Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Provexis's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Provexis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (LSE:PXS) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

PXS.GB:UK

Address

2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ

Website

https://www.provexis.com

Provexis PLC is a British food company. It is engaged in developing and licensing the Fruitflow, which is patented, natural, breakthrough ingredient which helps with platelet aggregation. Fruitflow reduces the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can result in heart attack and stroke. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.